| Deep Venous Thrombosis |
1 |
1 |
| Thromboembolism |
0 |
0.9 |
| Hepatocellular Carcinoma |
0 |
0.75 |
| Cancer |
0 |
0.71 |
| Breast Cancer |
0 |
0.69 |
| Metastasis |
0 |
0.68 |
| Ovarian Cancer |
0 |
0.65 |
| Liver Metastases |
0 |
0.62 |
| Pancreatic Cancer |
0 |
0.61 |
| Anticoagulation Therapy |
0 |
0.41 |
| CT Scan |
0 |
0.32 |
| Pulmonary Embolism |
0 |
0.31 |
| Chemotherapy |
0 |
0.26 |
| Venous Thromboembolism (VTE) |
0 |
0.24 |
| Adenocarcinoma of the Pancreas |
0 |
0.17 |
| Liver |
0 |
0.15 |
| Liver Biopsy |
0 |
0.15 |
| Scan |
0 |
0.15 |
| Diagnostic Liver Biopsy |
0 |
0.14 |
| Pregnancy |
0 |
0.12 |
| Adenocarcinoma |
0 |
0.1 |
| BRCA |
0 |
0.1 |
| Microsatellite Instability |
0 |
0.1 |
| Pancreas |
0 |
0.1 |
| Thorax |
0 |
0.1 |
| Abdominal Pain |
0 |
0.09 |
| Pain Management |
0 |
0.09 |
| Contraception |
0 |
0.07 |
| Sterilization, Birth Control |
0 |
0.07 |
| Abdomen |
0 |
0.05 |
| Adolescent Medicine |
0 |
0.05 |
| Biomarker |
0 |
0.05 |
| Biopsy |
0 |
0.05 |
| Birth |
0 |
0.05 |
| Dyspnea |
0 |
0.05 |
| Embolism |
0 |
0.05 |
| Factor II |
0 |
0.05 |
| Factor V |
0 |
0.05 |
| Heart |
0 |
0.05 |
| Lupus |
0 |
0.05 |
| Pain |
0 |
0.05 |
| Pennsylvania |
0 |
0.05 |
| Poly ADP-Ribose Polymerase (PARP) Inhibitor |
0 |
0.05 |
| Thrombosis |
0 |
0.05 |
| Vein |
0 |
0.05 |